Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
absence, analyzed, arm, augment, augmented, CEO, cloud, Codification, concept, concurrently, constraint, convenience, Corrupt, curtailed, customarily, database, Delaware, desirable, distinct, endpoint, EU, expedient, EXW, fall, field, FOB, forgo, formulation, fullest, GDPR, hand, havevolume, hosting, HYALOGRAFT, hybrid, incremental, insignificant, instance, interaction, landscape, licensee, MDR, mentioned, noncompliance, opening, paragraph, physician, placement, precautionary, predominant, promulgated, proof, prototype, quickly, randomization, ratified, reabsorbed, real, regimen, remeasured, remediation, resignation, resumed, sample, shelf, shipping, sophisticated, straight, Sunshine, tiered, twenty, UDI, unconditional, unilateral, unpaid, unsatisfied, viscosupplement, warranty, whichever
Removed:
accelerating, allocable, American, assured, begin, billed, buildout, buyer, calling, Chapter, collaborative, collection, commensurate, creation, determinable, discourage, distribute, earlier, earliest, Education, efficiency, element, empowered, enhance, enhancement, entirety, establishment, excise, funding, GAAP, graft, headcount, Hemostatic, holder, improve, INCERT, Junior, low, main, Malaysia, MDET, NE, necessarily, OPTIVISC, originally, par, Participating, passed, Patch, persuasive, pool, predecessor, preferred, promote, reassessed, redeemed, reliable, rendered, Restated, retail, Room, seller, shellgel, slightly, Street, substantive, tender, tightening, title, tracked, transitioning, Turkey, ultimate, undelivered, user, viscosupplementation, Washington
Filing tables
Filing exhibits
Related press release
Associated ANIK transcripts
ANIK similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements on Form S-8 (Nos. 333-06275, 333-66831, 333-79047, 333-58264, 333-110326, 333-160102, 333-176103, 333-190597 and 333-219190) of Anika Therapeutics, Inc. of our reports dated February 26, 2019, relating to the financial statements of Anika Therapeutics, Inc. (the “Company”), and the effectiveness of the Company's internal control over financial reporting, appearing in this Annual Report on Form 10-K of Anika Therapeutics, Inc. for the year ended December 31, 2018.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
February 26, 2019